Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    467942 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Cimzia Versus Mesalamine for Crohn's Recurrence
Condition: Crohn's Disease
Interventions: Drug: Cimzia;   Drug: Mesalamine

Study has passed its completion date and status has not been verified in more than two years.